Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 intradermal ELAPR formulations versus Restylane Vital Light in healthy volunteers
ACTRN12611001205921Phase 2Completed
- Sponsor
- Elastagen
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ELAPR002g in None, cutaneous aging, sponsored by Elastagen. Started Sep 2011; status: completed.
02
Drugs
ELAPR002g
03
Conditions
cutaneous aging
Beyond the preview
Go deeper on ACTRN12611001205921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001205921.